Invion Limited Dividend 2022

Invion Limited (IVX) is involved the global research and development of the Photosoft technology for the treatment of a range of cancers. Invion holds the Australia and New Zealand license and distribution rights to the Photosoft technology. Research and clinical trials are funded by the technology licensor, The Cho Group, via an R&D services agreement with the Company. The Group has operations in Australia and the United States with its wholly owned subsidiaries Invion Inc., Chronic Airway Therapeutics Limited and IVX Cosmetics Pty Ltd.

Invion Limited operators in Health Care sector and under industry of Pharmaceuticals. The company website is:

You can also check out dividend history for similar stocks in the same sector as follows:

IVX Dividend Dates

Please click the table header to sort the data.

No Dividend Dates Found